SCHEMBL23045967

SCHEMBL23045967

c1ccc(-n2c3ccccc3c3cc4c(cc32)nc2oc3ccccc3n24)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KDM4E B2RXH2 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 5/20 0.34
HSD17B10 Q99714 3/20 0.34
LMNA P02545 3/20 0.34
HPGD P15428 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 2/20 0.33
TSHR P16473 2/20 0.33
KMT2A Q03164 2/20 0.33
PTGER4 P35408 1/20 0.33
POLB P06746 1/20 0.33
BRCA1 P38398 1/20 0.33
MAPK1 P28482 2/20 0.33
HTT P42858 1/20 0.33
PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17507332 0.86 NPC1 (0.49) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL23903030 0.84 NPC1 (0.54) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL23903208 0.83 NPC1 (0.58) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL23903103 0.80 NPC1 (0.54) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL23903216 0.80 NPC1 (0.48) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL25500476 0.79 NPC1 (0.50) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL17507388 0.79 NPC1 (0.46) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL25500523 0.79 RAB9A (0.58) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL23903029 0.78 RAB9A (0.52) NPC1RAB9AKDM4EL3MBTL1ATM
SCHEMBL17507334 0.78 NPC1 (0.47) NPC1RAB9AKDM4EL3MBTL1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10934293-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934293-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, OPA1 NPC1 1873/4885RAB9A 2486/4885KDM4E 841/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.